BCM
PACB icon

BlueCrest Capital Management’s Pacific Biosciences PACB Stock Holding History

BlueCrest Capital Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-23,400
Closed -$271K – 292
2023
Q1 		$271K Buy
+23,400
New +$233K 0.01% 230
2019
Q4 		– Sell
-75,740
Closed -$391K – 529
2019
Q3 		$391K Buy
+75,740
New +$424K 0.03% 312
2018
Q4 		– Sell
-18,398
Closed -$100K – 1274
2018
Q3 		$100K Buy
+18,398
New +$78.9K ﹤0.01% 1385
2017
Q3 		– Sell
-43,585
Closed -$155K – 1030
2017
Q2 		$155K Buy
+43,585
New +$176K 0.01% 783

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return